Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

854
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
854
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

609
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
609
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

912
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
912
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

416
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
416
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

722
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
722
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

405
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
405

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial neural network potential for Au<sub>20</sub>clusters based on the first-principles.

Journal of physics. Condensed matter : an Institute of Physics journal·2022
Same author

Odor-producing response pattern by four typical freshwater algae under stress: Acute microplastic exposure as an example.

The Science of the total environment·2022
Same author

Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice.

Frontiers in immunology·2022
Same author

'C-type' closed state and gating mechanisms of K2P channels revealed by conformational changes of the TREK-1 channel.

Journal of molecular cell biology·2022
Same author

Treatment of Radiation-Induced Brain Necrosis.

Oxidative medicine and cellular longevity·2022
Same author

Effect of Nano-Silver on Formation of Marine Snow and the Underlying Microbial Mechanism.

Environmental science & technology·2022

Related Experiment Video

Updated: Jan 7, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

10.4K

Correlation between inflammatory markers and disease severity in ulcerative colitis.

Jie Fu1, Yue-Yu Zhang2,3

  • 1College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan 430065, Hubei Province, China. fujie266@126.com.

World Journal of Gastrointestinal Surgery
|January 2, 2026
PubMed
Summary

Systemic inflammatory markers like interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP) correlate with ulcerative colitis (UC) severity. Combined, these markers offer accurate disease progression prediction for personalized patient management.

Keywords:
C-reactive proteinDisease severityInflammatory markersInterleukin-6Predictive valueTumor necrosis factor-alphaUlcerative colitis

More Related Videos

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

68.7K
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

4.4K

Related Experiment Videos

Last Updated: Jan 7, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

10.4K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

68.7K
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

4.4K

Area of Science:

  • Gastroenterology
  • Immunology
  • Clinical Diagnostics

Background:

  • Histopathological examination via colonoscopy is the gold standard for diagnosing ulcerative colitis (UC).
  • Limitations of current diagnostic methods highlight the need for noninvasive biomarkers.
  • Assessing disease severity is crucial for effective UC management.

Purpose of the Study:

  • To evaluate the clinical relevance of systemic inflammatory markers in assessing UC disease severity.
  • To identify reliable noninvasive biomarkers for UC progression.
  • To explore the diagnostic performance of inflammatory markers in UC patients.

Main Methods:

  • 117 hospitalized UC patients were stratified by disease severity (mild, moderate, severe) using the modified Mayo score.
  • Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein (CRP) were measured.
  • Correlation and regression analyses were performed to assess marker relationships with disease severity and progression.

Main Results:

  • Serum IL-6, TNF-α, and CRP levels significantly increased with worsening UC severity.
  • All three inflammatory markers showed a strong positive correlation with disease severity.
  • A combined cytokine panel demonstrated superior diagnostic accuracy (AUC 0.917) compared to individual markers.

Conclusions:

  • IL-6, TNF-α, and CRP are reliable biomarkers for UC disease activity and progression.
  • Combined measurement of these markers aids in early identification of high-risk patients.
  • These biomarkers support prompt clinical intervention and personalized UC management.